Quick Answer
Syndax Pharmaceuticals Inc reported Total Assets of $529.71 million for fiscal year 2025.
Syndax Pharmaceuticals Inc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $529.71M | -26.9% |
| 2024 | $724.82M | +18.3% |
| 2023 | $612.88M | +23.3% |
| 2022 | $497.24M | +10.6% |
| 2021 | $449.66M | +49.6% |
| 2020 | $300.61M | +373.2% |
| 2019 | $63.52M | -24.3% |
| 2018 | $83.94M | -38.8% |
| 2017 | $137.19M | +25.8% |
| 2016 | $109.01M | +21.3% |
| 2015 | $89.90M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $551.79M | +29.6% | -7.4% |
| June 30, 2025 | $596.15M | +25.0% | -7.0% |
| March 31, 2025 | $640.71M | +18.0% | -11.6% |
| December 31, 2024 | $724.82M | +18.3% | +70.2% |
| September 30, 2024 | $425.81M | +6.7% | -10.7% |
| June 30, 2024 | $476.95M | +10.6% | -12.2% |
| March 31, 2024 | $543.03M | +18.1% | -11.4% |
| December 31, 2023 | $612.88M | +23.3% | +53.5% |
- Syndax Pharmaceuticals Inc showed a decrease of -26.9% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Syndax Pharmaceuticals Inc’s total assets has grown by 489.2% (from $89.90 million to $529.71 million).
- The most recent figure is from Syndax Pharmaceuticals Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: